What are the causes of splenomegaly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Splenomegaly

Splenomegaly is most commonly caused by liver disease, malignancy, and infection, with specific etiologies determined by targeted diagnostic testing and appropriate disease-specific treatment. 1

Major Categories of Splenomegaly

1. Hematologic Disorders

  • Malignancies:
    • Leukemias (chronic lymphocytic leukemia, chronic myeloid leukemia)
    • Lymphomas (Hodgkin and non-Hodgkin)
    • Myeloproliferative neoplasms (primary myelofibrosis, polycythemia vera) 2
  • Non-malignant:
    • Hemolytic anemias
    • Immune thrombocytopenia 2
    • Hereditary conditions (thalassemias, sickle cell disease)

2. Infectious Causes

  • Bacterial: Endocarditis, tuberculosis, brucellosis
  • Viral: Infectious mononucleosis (EBV), HIV, viral hepatitis
  • Parasitic: Malaria, schistosomiasis (particularly common in tropical regions) 1
  • Fungal: Histoplasmosis

3. Liver Disease and Portal Hypertension

  • Cirrhosis (alcoholic, viral, non-alcoholic steatohepatitis)
  • Portal or splenic vein thrombosis
  • Budd-Chiari syndrome
  • Portal hypertension (defined as hepatic venous pressure gradient >6 mmHg) 1

4. Inflammatory and Autoimmune Disorders

  • Systemic lupus erythematosus 2
  • Rheumatoid arthritis (especially with Felty's syndrome)
  • Sarcoidosis
  • Amyloidosis

5. Infiltrative Disorders

  • Gaucher disease
  • Niemann-Pick disease
  • Glycogen storage diseases
  • Amyloidosis

6. Other Causes

  • Splenic cysts or tumors
  • Congestive heart failure
  • Splenic artery aneurysm
  • Splenic sequestration crisis in sickle cell disease

Diagnostic Approach

Initial Evaluation

  • Complete blood count with differential to evaluate for cytopenias or elevated cell counts 1
  • Liver function tests to assess for liver disease 1
  • Abdominal ultrasound to confirm splenomegaly (>13 cm is considered enlarged) 2, 1

Further Investigations Based on Initial Findings

  • Bone marrow examination for suspected hematologic malignancies 1
  • Testing for infectious causes based on risk factors and exposure history
  • Genetic testing for suspected hereditary conditions 1

Important Clinical Considerations

Physical Examination Findings

  • Mild splenomegaly may be found in younger patients with ITP 2
  • Moderate or massive splenomegaly suggests alternative causes like lymphoproliferative disorders 2
  • Constitutional symptoms (fever, weight loss), hepatomegaly, or lymphadenopathy might indicate underlying disorders such as HIV, SLE, or lymphoproliferative disease 2

Complications of Splenomegaly

  • Hypersplenism leading to cytopenias, particularly thrombocytopenia
  • Increased risk of splenic rupture (patients should avoid contact sports) 1
  • Portal hypertension and its sequelae
  • Splenic infarction

Pitfalls to Avoid

  • Failing to recognize malignant infiltration in patients with massive hepatosplenomegaly 1
  • Overlooking splenic sequestration as a life-threatening complication in sickle cell disease 1
  • Underestimating the risks of splenectomy in patients with portal hypertension 1
  • Performing splenectomy in patients with severe thrombocytopenia, which may be a marker of impending leukemic transformation 1

Management Considerations

  • Treatment is directed at the underlying cause of splenomegaly 1
  • For symptomatic splenomegaly in myeloproliferative disorders, hydroxyurea is the first-line treatment 2, 1
  • Splenectomy may be considered for:
    • Symptomatic portal hypertension
    • Drug-refractory painful splenomegaly
    • Severe cachexia associated with splenomegaly
    • Transfusion-dependent anemia 2, 1
  • Perioperative mortality of splenectomy is 5-10%, with complications in approximately 50% of patients 2, 1

By systematically evaluating patients with splenomegaly using this approach, clinicians can identify the underlying cause and implement appropriate disease-specific treatment to improve outcomes.

References

Guideline

Management of Abdominal Organ Enlargement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.